相关实验视频
Updated: Sep 9, 2025

16:15
Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
20.9K
改善已故捐赠的利用率:通过可解释的模型预测不使用的风险
Ruoting Li1, Sait Tunç2, Osman Y Özaltın3
1Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
Frontiers in artificial intelligence
|August 29, 2025
概括
简化模型预测未使用的已故捐赠脏, 改善器官分配. 这些工具有助于识别高危脏及时移植,解决器官短缺问题.
科学领域:
- 肝脏病学
- 移植医学
- 医疗服务研究
背景情况:
- 许多已故的捐赠脏没有被用于移植, 尽管需求很高.
- 早期识别处于不使用风险的对于实施有效的分配策略至关重要.
- 现有的复杂机器学习模型用于预测不使用的风险在实际实施中面临挑战.
研究的目的:
- 开发简化和可实施的模型来预测已故捐赠脏未使用的风险.
- 加强脏不使用风险预测在器官分配中的实际应用.
主要方法:
- 拟议的简化模型将捐赠者风险指数 (KDRI) 与通过机器学习或专家输入识别的有限变量集结在一起.
- 在预测模型中影响脏配置的纳入器官采购组织 (OPO) 层面的因素.
- 验证了简化模型与更复杂,多变量方法的性能.
主要成果:
- 与复杂,数据密集型模型相比,开发的简化模型实现了竞争性预测性能.
- 拟议的模型在临床实践中提供了更好的解释性和易用性.
- 确定了导致脏不使用的关键因素,包括器官采购组织 (OPO) 实践的变化.
结论:
- 简化,可解释的模型准确预测已故捐赠的不使用风险.
- 这些模型可以指导开发有针对性的干预措施,以增加移植率,特别是"难以到位"的器官.
- 了解OPO特定的变异对于优化器官分配策略至关重要.
相关概念视频
Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
Pharmacokinetic Models: Comparison and Selection Criterion
147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
Pharmacokinetic Models: Overview
1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
Physiological Pharmacokinetic Models: Assumption with Protein Binding
91
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
91
Kidney Transplant II: Surgical Procedure
75
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
75

